HOUSTON, Sept. 3, 2025 /PRNewswire/ — RBL LLC, a pioneering biotech venture creation studio dedicated to rapidly building companies based on breakthrough medical technologies, today announced a strategic investment from Carnrite Ventures that will support the rapid development of its growing pipeline of therapeutic companies.
“Carnrite’s investment validates our thesis that the future of biotech lies in purpose-built platforms that can systematically translate academic breakthroughs into commercial success,” said Paul Wotton, RBL’s managing partner. “Carnrite recognizes the value we have created through our integrated approach here in Houston’s thriving life sciences ecosystem, and their backing enables us to scale this model while continuing to attract the world’s best scientific talent to what is rapidly becoming one of the nation’s premier biotech hubs.”
“What sets RBL apart is their ability to identify and develop the highest-impact opportunities from exceptional research institutions, all while leveraging Houston’s unique advantages as a biotech destination,” said Jeff Carnrite, partner at Carnrite Ventures. “We are backing a proven team that has created a repeatable process for building companies that matter. The combination of Rice University’s innovation depth with RBL’s disciplined approach and Houston’s world-class medical infrastructure represents exactly the kind of scalable platform we look for in our investments.”
The partnership comes as RBL reaches a critical inflection point with portfolio companies advancing a robust pipeline of emerging technologies. Carnrite’s investment will directly support RBL’s expanded operations and accelerate the translation of innovative discoveries into patient-ready therapies.
About RBL LLC:
RBL LLC is a pioneering biotech venture creation studio based in Houston that is dedicated to accelerating the development of breakthrough medical technologies and therapies through company formation. RBL provides entrepreneurs, researchers and innovators with infrastructure, financial support and strategic guidance as well as access to laboratory space and shared resources in the Texas Medical Center Helix Park. For more information, please visit https://www.rbl-llc.com/.
About Carnrite Ventures:
Carnrite Ventures is a Houston-based venture capital firm investing in disruptive technology companies across the United States. With $25 million under management, the firm partners with world-class entrepreneurs building transformative energy, industrial, and healthcare technology companies from the earliest stages. In addition to capital, Carnrite Ventures provides sector expertise and strategic support to accelerate growth. For more information, please visit https://www.carnriteventures.com.
Media Contact:
Russo Partners
David Schull or Liz Phillips
(347) 956-7697
[email protected]
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/rbl-llc-secures-investment-from-carnrite-ventures-302541417.html
SOURCE RBL LLC
